28328-71-4Relevant articles and documents
SAR Studies and Biological Characterization of a Chromen-4-one Derivative as an Anti- Trypanosoma brucei Agent
Borsari, Chiara,Santarem, Nuno,MacEdo, Sara,Jiménez-Antón, María Dolores,Torrado, Juan J.,Olías-Molero, Ana Isabel,Corral, María J.,Tait, Annalisa,Ferrari, Stefania,Costantino, Luca,Luciani, Rosaria,Ponterini, Glauco,Gul, Sheraz,Kuzikov, Maria,Ellinger, Bernhard,Behrens, Birte,Reinshagen, Jeanette,Alunda, José María,Cordeiro-Da-Silva, Anabela,Costi, Maria Paola
supporting information, p. 528 - 533 (2019/04/25)
Chemical modulation of the flavonol 2-(benzo[d][1,3]dioxol-5-yl)-chromen-4-one (1), a promising anti-Trypanosomatid agent previously identified, was evaluated through a phenotypic screening approach. Herein, we have performed structure-activity relationsh
CDK inhibitors having flavone structure
-
, (2008/06/13)
The present invention relates to a novel flavone derivative, pharmaceutically acceptable salt, hydrate, solvate and isomer thereof which is useful as an inhibitor against Cyclin Dependent Kinase (CDK), a process for preparation thereof, and a composition of anti-cancer agent or agent for treating neurodegenerative disease comprising this compound as an active ingredient.